Clinica
Thoratec investor urges firm to put itself up for sale after "unsatisfactory" growth
07 December 2011
Madeleine Armstrong
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- Thoratec issues safety alert on HeartMate II; could rival HeartWare benefit?
- Thoratec cements No1 heart support position with Levitronix Medical acquisition
- Quarterly results round-up: Dentsply and Thoratec see double-digit sales growth, while Fresenius doubles income
- HeartWare stock rises in run-up to FDA panel vote despite concerns
Other Informa News
EVENTS
